Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Merck Serono returns Parkinson’s drug rights to Newron

October 24, 2011 Research and Development, Sales and Marketing Merck Serono, Newron

Merck Serono has returned the rights to the Parkinson’s disease drug safinamide back to Newron. The decision comes after the …
News

Abbott spin-off could attract mega merger

October 21, 2011 Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …
News
abpi

UK research cannot rest on its laurels, warns ABPI

October 21, 2011 Medical Communications, Research and Development ABPI, NHS, R&D

The ABPI has warned that the UK must continue to attract investment for research, or risk being superseded by emerging …
News
Abbott

Abbott to split into two separate companies

October 20, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Abbott Laboratories

Abbott’s management has decided to split the company into two separate entities in order to give shareholders a ‘distinct investment …
News
GSK

Rumours abound on GSK-HGS takeover bid

October 20, 2011 Research and Development, Sales and Marketing Benlysta, GSK, HGS

Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …
News
Herceptin image

Injectable Herceptin proves its worth

October 20, 2011 Research and Development, Sales and Marketing Herceptin, Roche

An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …
News

Medical Devices: Harmonisation of Requirements for Address of Manufacturer

October 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The inclusion of the manufacturer’s address on the labels and instructions for use is an Essential Requirement according to the …
News
Press release

Opportunity to Realise the Value of Dormant UK Authorisations before December Deadline

October 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …
News
Press release
malaria vaccine trial

GSK malaria vaccine cuts disease risk by half

October 19, 2011 Research and Development malaria, malaria vaccine

Results from GSK’s malaria vaccine trial have excited observers after it reduced the risk of the disease by half. Data …
News

European judge rules against stem cell patents

October 19, 2011 Research and Development Stem cells, patents

The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …
News
ralf_huss

German biotech Apceth appoints Prof. Ralf Huss

October 19, 2011 Research and Development appointment, research and development

Munich-based biotech Apceth has appointed Prof Ralf Huss to its management board. Prof Huss moves to the company from Roche, …
Appointment
Lundbeck headquarters, Denmark

Lundbeck establishes research centre in China

October 18, 2011 Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets

Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …
News

EMA resources stretched by Mediator scandal

October 18, 2011 Research and Development, Sales and Marketing EMA, Mediator

The European Medicines Agency has been forced to use ‘considerable resources’ to deal with a flood of enquiries over Mediator …
News
Roche

Roche buys US firm Anadys for $230 million

October 17, 2011 Research and Development, Sales and Marketing Roche, hepatitis C

Roche has acquired US firm Anadys for $230 million, bolstering its infectious drugs pipeline. California-based Anadys develops oral, small molecule …
News

Quintiles opens new European headquarters in the UK

October 12, 2011 Research and Development Quintiles, research and development news

Pharmaceutical services company Quintiles has opened a new European headquarters in the UK. The Reading, Berkshire facility will house more …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026